Hosted on MSN

Talphera signals study completion in first half of 2026 as new site activations delay NEPHRO timeline

Due to the delays in activating new clinical sites, Talphera now anticipates study completion in the first half of 2026, moving back from its previous expectation of year-end 2025. The company is ...
Seeking Alpha

Talphera outlines 2025 timeline for NEPHRO CRRT study completion and FDA approval of Niyad

CEO Vincent Angotti highlighted significant progress in the NEPHRO CRRT study, emphasizing the FDA-approved reduction in study size from 166 to 70 patients while maintaining 90% statistical power for ...